Vertex Pharmaceuticals Incorporated vs Bristol-Myers Squibb Company
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
Vertex Pharmaceuticals Incorporated
$130.6B
์์ #131
Bristol-Myers Squibb Company
$132.0B
์์ #127
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- Vertex Pharmaceuticals Incorporated์ด(๊ฐ) 2023๋ ๊น์ง Bristol-Myers Squibb Company์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Bristol-Myers Squibb Company์ด(๊ฐ) 2024๋ ๊น์ง Vertex Pharmaceuticals Incorporated์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Vertex Pharmaceuticals Incorporated์ด(๊ฐ) 2025๋ ๊น์ง Bristol-Myers Squibb Company์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Bristol-Myers Squibb Company์ด(๊ฐ) 2026๋ ๊น์ง Vertex Pharmaceuticals Incorporated์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | Vertex Pharmaceuticals Incorporated | Bristol-Myers Squibb Company | ์ ๋ |
|---|---|---|---|
| 2026 | $130.6B | $132.0B | Bristol-Myers Squibb Company |
| 2025 | $115.1B | $107.8B | Vertex Pharmaceuticals Incorporated |
| 2024 | $102.2B | $107.6B | Bristol-Myers Squibb Company |
| 2023 | $103.3B | $92.9B | Vertex Pharmaceuticals Incorporated |
| 2022 | $73.3B | $125.8B | Bristol-Myers Squibb Company |
| 2021 | $55.7B | $105.8B | Bristol-Myers Squibb Company |
| 2020 | $60.0B | $102.0B | Bristol-Myers Squibb Company |
| 2019 | $55.6B | $102.4B | Bristol-Myers Squibb Company |
| 2018 | $42.1B | $80.2B | Bristol-Myers Squibb Company |
| 2017 | $38.0B | $92.0B | Bristol-Myers Squibb Company |
| 2016 | $18.7B | $85.4B | Bristol-Myers Squibb Company |
| 2015 | $31.9B | $98.2B | Bristol-Myers Squibb Company |
| 2014 | $30.2B | $82.3B | Bristol-Myers Squibb Company |
| 2013 | $18.9B | $72.0B | Bristol-Myers Squibb Company |
| 2012 | $10.6B | $42.7B | Bristol-Myers Squibb Company |
| 2011 | $8.4B | $44.4B | Bristol-Myers Squibb Company |
| 2010 | $8.9B | $31.8B | Bristol-Myers Squibb Company |
| 2009 | $10.9B | $28.9B | Bristol-Myers Squibb Company |
| 2008 | $7.7B | $25.1B | Bristol-Myers Squibb Company |
| 2007 | $5.9B | $27.1B | Bristol-Myers Squibb Company |
| 2006 | $9.5B | $25.9B | Bristol-Myers Squibb Company |
| 2005 | $7.0B | $21.6B | Bristol-Myers Squibb Company |
| 2004 | $2.7B | $23.0B | Bristol-Myers Squibb Company |
| 2003 | $2.6B | $24.5B | Bristol-Myers Squibb Company |
| 2002 | $4.0B | $19.0B | Bristol-Myers Squibb Company |
| 2001 | $6.2B | $40.3B | Bristol-Myers Squibb Company |
| 2000 | $18.1B | $54.6B | Bristol-Myers Squibb Company |
| 1999 | $4.4B | $46.6B | Bristol-Myers Squibb Company |
| 1998 | $3.8B | $48.0B | Bristol-Myers Squibb Company |
| 1997 | $4.2B | $33.4B | Bristol-Myers Squibb Company |
| 1996 | $5.1B | $18.8B | Bristol-Myers Squibb Company |
| 1995 | $3.4B | $14.3B | Bristol-Myers Squibb Company |
| 1994 | $1.9B | $9.2B | Bristol-Myers Squibb Company |